文献速递糖尿病

心血管代谢生物标志物负担与心肾代谢共病进展的转变特异性关联

Transition‐Specific Associations of Cardiometabolic Biomarker Burden With Cardio‐Renal‐Metabolic Multimorbidity Progression: A Multistate Cohort Study
RSS 订阅 · Diabetes, Obesity and Metabolism · 2026-10-14

研究选出5项代表性标志物并构建加权5项心血管代谢风险评分,显示最高评分组在三个序贯转变中的风险比为2.80、1.84和1.71。

要点

  • 五项标志物为C反应蛋白/白蛋白比值、METS-IR、甘油三酯/HDL-C比值、腰高比和收缩压。
  • 最高5-CMRS组的三步转变风险比分别为2.80、1.84和1.71。
  • METS-IR在各转变中相对贡献最大,累加交互主要在早期阶段观察到。

核心结论

  • 联合心血管代谢生物标志物负担与心肾代谢共病进展的序贯转变呈现分级且转变特异性关联。

主要发现

  • 筛选出5项代表性生物标志物:C反应蛋白/白蛋白比值、METS-IR、甘油三酯/HDL胆固醇比值、腰高比和收缩压。
  • 较高标志物升高计数在所有转变中显示分级关联。
  • 与最低5-CMRS类别相比,最高类别在三个序贯转变中的风险比分别为2.80、1.84和1.71。
  • 疾病特异性分析显示与新发2型糖尿病的关联最强。

关键数值与推荐

  • 最高5-CMRS类别相对最低类别的三个序贯转变风险比:2.80、1.84、1.71。
  • 中位随访时间15.62年。

临床怎么用

  • 支持在炎症、代谢、肥胖、血脂和血压各域进行整合心血管代谢风险评估。
  • METS-IR在各转变中相对贡献最大,可作为重点关注指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Aims To identify representative cardiometabolic biomarkers and examine how individual biomarkers and combined biomarker burden are associated with transition-specific progression of cardio-renal-metabolic multimorbidity (CRMM). Methods This prospective cohort study included 262 464 UK Biobank participants free of cardiovascular disease (CVD), type 2 diabetes (T2D) and chronic kidney disease (CKD) at baseline. Forty-nine candidate biomarkers across five domains, including inflammation, insulin resistance, dyslipidemia, adiposity and blood pressure, were evaluated using time-dependent area under the curve and concordance index to select representative markers. Multistate models estimated associations of individual biomarkers, elevated-marker count and a weighted 5-Item Cardiometabolic Risk Score (5-CMRS) with sequential transitions from baseline to first cardio-renal-metabolic disease (FCRMD), FCRMD to Double CRMD and Double to Triple CRMD. Results During a median follow-up of 15.62 years, 44 339 participants developed FCRMD, 7218 progressed to Double CRMD and 721 progressed to Triple CRMD. Five representative biomarkers were selected: C-reactive protein-to-albumin ratio, metabolic score for insulin resistance (METS-IR), triglyceride-to-HDL cholesterol ratio, waist-to-height ratio and systolic blood pressure. Higher elevated-marker count showed graded associations across all transitions. Compared with the lowest 5-CMRS category, the highest category was associated with hazard ratios of 2.80, 1.84 and 1.71 for the three sequential transitions. Disease-specific analyses showed the strongest associations with incident T2D. METS-IR showed the largest relative contributions across all transitions, whereas additive interactions were mainly observed during early CRMM progression. Conclusion Combined cardiometabolic biomarker burden was associated with graded, transition-specific risks across CRMM progression, supporting integrated cardiometabolic risk assessment across inflammatory, metabolic, adiposity, lipid and blood-pressure domains.

来源:Diabetes, Obesity and Metabolism,查看原文。版权归原作者所有。

引用

  1. Diabetes, Obesity and Metabolism:Transition‐Specific Associations of Cardiometabolic Biomarker Burden With Cardio‐Renal‐Metabolic Multimorbidity Progression: A Multistate Cohort Study

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。